Search

everythinglearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Vorasidenib can cause unusual hair growth.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Sonidegib and vismodegib have different side effects and reporting patterns.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Stopping S100A3 activity slows down hair growth in mice.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

GRF is not safe for tubal occlusion.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

A new gene mutation linked to KID syndrome was found, expanding genetic knowledge.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Lower SMAD2/3 activation predicts more severe skin cancer.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

Axitinib treatment turned a man's grey hair back to black.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.